XT
IGC icon

XTX Topco’s IGC Pharma IGC Stock Holding History

XTX Topco’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Sell
39,378
-11,270
-22% -$3.33K ﹤0.01% 4018
2026
Q1 		$13.3K Buy
50,648
+22,324
+79% +$6.2K ﹤0.01% 3635
2025
Q4 		$7.97K Sell
28,324
-5,679
-17% -$2.02K ﹤0.01% 3210
2025
Q3 		$14.2K Buy
34,003
+20,238
+147% +$7.7K ﹤0.01% 2386
2025
Q2 		$4.21K Sell
13,765
-18,318
-57% -$5.5K ﹤0.01% 2261
2025
Q1 		$9.14K Buy
+32,083
New +$10.1K ﹤0.01% 2260
2024
Q2 		– Sell
-29,272
Closed -$11.7K – 2138
2024
Q1 		$11.7K Buy
+29,272
New +$9.09K ﹤0.01% 1665

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

XTX Topco's IGC Position: Q2 2026 in Review

XTX Topco reduced its IGC Pharma (IGC) stake by 22% in Q2 2026, selling an estimated $3.33K and leaving 39,378 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4018.

XTX Topco first reported a position in IGC in Q1 2024 and has held it in 7 quarters since. The position peaked at $14.2K in Q3 2025. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • XTX Topco held 39,378 shares of IGC Pharma worth $10.7K as of Q2 2026.
  • XTX Topco sold 11,270 IGC Pharma shares in Q2 2026, an estimated $3.33K.
  • IGC Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4018 holding.
  • XTX Topco first reported a position in IGC Pharma in Q1 2024 and has held it in 7 quarters since.
  • XTX Topco's IGC Pharma position peaked at $14.2K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.